Delivery Order SPE2DB24D2100-SPE2DB25FBBEU

Award Date 12/9/24
Potential Completion Date 12/10/24
Potential Value $64K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB25FBBEU
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $63,979.36, is for the delivery of ELIQUIS 5 MG TABLET 60S, with a completion date of December 10, 2024. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen, a for-profit organization, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 3/10/25, 9:51 AM